tiprankstipranks

Christopher Hite Insider Profile

4 Followers
Christopher Hite, EVP & Chairman, Partnering at Royalty Pharma, holds 393.60K shares in Royalty Pharma (Ticker: RPRX), holds ― shares in Vera Therapeutics (Ticker: VERA), holds ― shares in Kailera Therapeutics, Inc. (Ticker: KLRA).
tipranks
Christopher Hite

Christopher Hite
Royalty Pharma (RPRX)
EVP & Chairman, Partnering

Not Ranked
Christopher Hite has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23M
100.00%
0.00%
0.00%
A breakdown of Christopher Hite's holdings

Insider Roles

Royalty Pharma
(RPRX)
EVP & Chairman, Partnering
Vera Therapeutics
(VERA)
Director
Kailera Therapeutics, Inc.
(KLRA)
Director
Roles that Christopher Hite holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Christopher Hite

Christopher Hite's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Royalty Pharma
Aug 19, 2026
EVP & Chairman, Partnering
Uninformative Sell
$23.12M
Vera Therapeutics
Director
Kailera Therapeutics, Inc.
Director
XLRN
Acceleron Pharma
Nov 22, 2021
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Christopher Hite's performance on stock

Christopher Hite insider profile FAQ

What is the percentage of profitable transactions made by Christopher Hite?
The percentage of profitable transactions made by Christopher Hite is ―.
    What is the average return per transaction made by Christopher Hite?
    The average return per transaction made by Christopher Hite is ―.
      What stocks does Christopher Hite hold?
      Christopher Hite holds: RPRX, VERA, KLRA, XLRN stocks.
        What was Christopher Hite’s latest transaction?
        Christopher Hite latest transaction was an Uninformative Sell of ―.
          What was Christopher Hite's most profitable transaction?
          Christopher Hite’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Christopher Hite's role in Royalty Pharma?
            Christopher Hite's role in Royalty Pharma is EVP & Chairman, Partnering.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.